SCHEMBL24264732

SCHEMBL24264732

CNC(Cc1ccccc1)C(=O)C(C)=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 2/20 0.48
▸ SLC18A2 Q05940 1/20 0.48
▸ SIGMAR1 Q99720 1/20 0.48
▸ CTSS P25774 1/20 0.48
▸ CTSK P43235 1/20 0.48
▸ PAM P19021 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ ALPI P09923 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ XIAP P98170 1/20 0.47
▸ SLC7A5 Q01650 1/20 0.47
▸ CTRB1 P17538 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MME P08473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24264730 0.87 TAAR1 (0.50) TAAR1SLC18A2SIGMAR1CTSSCTSK
SCHEMBL2628426 0.85 TAAR1 (0.52) TAAR1SLC18A2SIGMAR1CTSSCTSK
SCHEMBL8318346 0.85 TAAR1 (0.52) TAAR1SLC18A2SIGMAR1CTSSCTSK
SCHEMBL8175870 0.85 TAAR1 (0.52) TAAR1SLC18A2SIGMAR1CTSSCTSK
SCHEMBL38479 0.83 MME (0.57) TAAR1SLC18A2SIGMAR1CYP1A2L3MBTL1
SCHEMBL38480 0.83 MME (0.57) TAAR1SLC18A2SIGMAR1CYP1A2L3MBTL1
SCHEMBL161255 0.83 MME (0.57) TAAR1SLC18A2SIGMAR1CYP1A2L3MBTL1
SCHEMBL7937827 0.83 MME (0.57) TAAR1SLC18A2SIGMAR1CYP1A2L3MBTL1
SCHEMBL27540746 0.82 NPSR1 (0.52) CTSSCTSKPAMNPC1RAB9A
SCHEMBL1324550 0.81 MME (0.56) TAAR1SLC18A2SIGMAR1CYP1A2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022038417-A2 MODIFIED IL-18 POLYPEPTIDES AND USES THEREOF BRIGHT PEAK THERAPEUTICS AG (CH) 2022-02-24 — — WO disclosed
Send feedback